All Posts

Cost effectiveness of a novel SwaRSA Strategy to reduce acute exacerbations of COPD

The paper discusses the significant economic burden of Chronic Obstructive Pulmonary Disease (COPD) and the potential cost savings from...

bellagio2018

May 22 min read